Similar articles

• Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.

  Shah PK, Narendran V, Tawansy KA, Raghuram A, Narendran K. Shah PK, et al. Indian J Ophthalmol. 2007 Jan-Feb;55(1):75-6. doi: 10.4103/0301-4738.29505. Indian J Ophthalmol. 2007. PMID: 17189897
• Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.

  Chung EJ, Kim JH, Ahn HS, Koh HJ. Chung EJ, et al. Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1727-30. doi: 10.1007/s00417-007-0661-y. Epub 2007 Aug 10. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17690897
• Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.

  Azad R, Chandra P. Azad R, et al. Indian J Ophthalmol. 2007 Jul-Aug;55(4):319; author reply 320. doi: 10.4103/0301-4738.33057. Indian J Ophthalmol. 2007. PMID: 17595491 No abstract available.
• [Retinopathy of prematurity - therapy. Part 2].

  Prepiaková Z, Tomčíková D, Kostolná B, Gerinec A. Prepiaková Z, et al. Cesk Slov Oftalmol. 2014 Apr;70(2):50-4. Cesk Slov Oftalmol. 2014. PMID: 25030312 Review. Czech.
• A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.

  Patel CK, Walker NJ, Kam JK. Patel CK, et al. Br J Ophthalmol. 2010 Aug;94(8):1107-9. doi: 10.1136/bjo.2009.162156. Epub 2010 Jun 16. Br J Ophthalmol. 2010. PMID: 20558426 Review. No abstract available.